A leading oncologist has issued a stark generational health warning, stating that men born before 1970 carry a significantly higher genetic risk of developing aggressive prostate cancer.
Professor Robert Thomas, a consultant oncologist with over 25 years of experience, emphasises that this specific age group faces a 'perfect storm' of genetic predisposition and historically lower public awareness. This combination has created a critical health disparity that demands immediate attention.
The Genetic Divide
Professor Thomas explains that the genetic profile of prostate cancer has evolved. Men born in earlier decades inherited a different set of risk factors compared to those born after 1970. This isn't about lifestyle choices; it's deeply rooted in their DNA, making them inherently more susceptible to aggressive forms of the disease.
Why Screening is Non-Negotiable
The professor's advice is unequivocal: men over 50, and particularly those with a family history of cancer, must seek proactive screening. He strongly advocates for a PSA (Prostate-Specific Antigen) blood test, a simple procedure that can be discussed with a GP.
'Early detection is absolutely paramount,' Professor Thomas states. 'The difference between catching prostate cancer early and late is the difference between treatable and terminal. A five-minute conversation with your doctor could literally save your life.'
Symptoms You Must Not Ignore
While early-stage prostate cancer often has no symptoms, being aware of potential signs is vital. These can include:
- An increased need to urinate, especially at night.
- Difficulty starting or stopping urination.
- A weak or interrupted urine flow.
- A feeling that your bladder hasn't emptied fully.
- Less common signs include blood in urine or semen and pain in the back, hips, or pelvis.
Professor Thomas urges any man experiencing these symptoms to contact their GP without delay, reassuring them that 'it's probably nothing serious, but getting it checked is everything.'
A Call to Action for Public Health
This revelation underscores a pressing need for targeted public health campaigns aimed at this higher-risk demographic. Raising awareness and encouraging open conversations about men's health could lead to earlier diagnoses, more effective treatments, and ultimately, thousands of lives saved across the UK.
